Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of an investigational blood/body fluid agent vs darbepoetin alfa
jRCT2080222385Phase 2Completed
- Start
- Feb 2014
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2 trial of darbepoetin alfa (2 arms). Started Feb 2014; status: completed.
02
Drugs
darbepoetin alfa
Beyond the preview
Go deeper on jRCT2080222385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222385.